Viewpoint: Mandating Vaccinations Should Depend on Company Culture

With the March announcement that pharmaceutical giant Merck will help rival Johnson & Johnson manufacture J&J's Covid vaccine, President Joe Biden's promise to have enough shots for every adult by the end of May appears to be on track. The light at the end of a long tunnel is brightening, and companies can finally plan, in earnest, a return to in-person work.
Read more...

;